Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 1578 | 7.945 |
09:34 ET | 200 | 8.015 |
09:39 ET | 1400 | 7.89 |
09:41 ET | 1542 | 7.8 |
09:43 ET | 100 | 7.78 |
09:45 ET | 100 | 7.88 |
09:48 ET | 400 | 7.77 |
09:50 ET | 100 | 7.685 |
09:54 ET | 100 | 7.685 |
09:56 ET | 300 | 7.67 |
09:57 ET | 100 | 7.65 |
09:59 ET | 100 | 7.655 |
10:03 ET | 800 | 7.77 |
10:06 ET | 200 | 7.82 |
10:10 ET | 100 | 7.77 |
10:14 ET | 100 | 7.76 |
10:17 ET | 300 | 7.76 |
10:21 ET | 100 | 7.7 |
10:26 ET | 600 | 7.735 |
10:35 ET | 400 | 7.74 |
10:46 ET | 100 | 7.695 |
10:48 ET | 110 | 7.7251 |
10:55 ET | 100 | 7.64 |
11:02 ET | 100 | 7.64 |
11:04 ET | 128 | 7.64 |
11:06 ET | 100 | 7.605 |
11:09 ET | 100 | 7.59 |
11:11 ET | 2899 | 7.525 |
11:13 ET | 1800 | 7.465 |
11:15 ET | 2785 | 7.49 |
11:18 ET | 1332 | 7.42 |
11:20 ET | 16825 | 7.2 |
11:22 ET | 9852 | 7.44 |
11:31 ET | 500 | 7.52 |
11:33 ET | 900 | 7.57 |
11:38 ET | 2756 | 7.59 |
11:40 ET | 100 | 7.65 |
11:45 ET | 200 | 7.615 |
11:51 ET | 3699 | 7.66 |
11:54 ET | 200 | 7.66 |
11:56 ET | 200 | 7.73 |
11:58 ET | 100 | 7.73 |
12:00 ET | 200 | 7.75 |
12:02 ET | 1589 | 7.715 |
12:03 ET | 100 | 7.75 |
12:05 ET | 300 | 7.71 |
12:14 ET | 100 | 7.745 |
12:16 ET | 100 | 7.7 |
12:18 ET | 100 | 7.66 |
12:20 ET | 200 | 7.6701 |
12:21 ET | 500 | 7.71 |
12:23 ET | 1555 | 7.74 |
12:25 ET | 570 | 7.75 |
12:27 ET | 100 | 7.76 |
12:34 ET | 100 | 7.76 |
12:36 ET | 100 | 7.72 |
12:39 ET | 300 | 7.75 |
12:41 ET | 100 | 7.77 |
12:45 ET | 200 | 7.82 |
12:57 ET | 600 | 7.805 |
01:01 ET | 100 | 7.79 |
01:03 ET | 200 | 7.796 |
01:08 ET | 200 | 7.775 |
01:10 ET | 300 | 7.77 |
01:14 ET | 100 | 7.76 |
01:17 ET | 200 | 7.75 |
01:19 ET | 200 | 7.75 |
01:21 ET | 100 | 7.75 |
01:24 ET | 500 | 7.75 |
01:28 ET | 298 | 7.75 |
01:30 ET | 100 | 7.745 |
01:32 ET | 200 | 7.75 |
01:35 ET | 595 | 7.765 |
01:46 ET | 225 | 7.78 |
01:50 ET | 300 | 7.83 |
01:51 ET | 1600 | 7.76 |
01:55 ET | 4000 | 7.79 |
01:57 ET | 100 | 7.76 |
02:02 ET | 100 | 7.75 |
02:04 ET | 1639 | 7.78 |
02:08 ET | 200 | 7.77 |
02:13 ET | 100 | 7.75 |
02:15 ET | 300 | 7.77 |
02:20 ET | 1800 | 7.81 |
02:22 ET | 100 | 7.81 |
02:24 ET | 100 | 7.83 |
02:26 ET | 121 | 7.8435 |
02:29 ET | 100 | 7.835 |
02:31 ET | 100 | 7.84 |
02:33 ET | 300 | 7.82 |
02:36 ET | 500 | 7.805 |
02:40 ET | 200 | 7.78 |
02:44 ET | 200 | 7.77 |
02:49 ET | 100 | 7.77 |
02:54 ET | 800 | 7.745 |
02:58 ET | 100 | 7.745 |
03:02 ET | 100 | 7.74 |
03:03 ET | 1157 | 7.77 |
03:12 ET | 1564 | 7.8 |
03:16 ET | 100 | 7.79 |
03:21 ET | 100 | 7.76 |
03:23 ET | 367 | 7.76 |
03:25 ET | 602 | 7.745 |
03:27 ET | 300 | 7.74 |
03:34 ET | 200 | 7.745 |
03:36 ET | 100 | 7.745 |
03:38 ET | 1200 | 7.79 |
03:39 ET | 800 | 7.82 |
03:41 ET | 600 | 7.86 |
03:43 ET | 300 | 7.84 |
03:45 ET | 200 | 7.87 |
03:48 ET | 400 | 7.84 |
03:50 ET | 954 | 7.84 |
03:52 ET | 3677 | 7.75 |
03:54 ET | 3087 | 7.75 |
03:56 ET | 4756 | 7.75 |
03:57 ET | 9684 | 7.755 |
03:59 ET | 5018 | 7.73 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 431.9M | -8.7x | --- |
Cibus Inc | 422.5M | -0.8x | --- |
Nano-X Imaging Ltd | 539.9M | -8.8x | --- |
Orchestra Biomed Holdings Inc | 182.5M | -3.5x | --- |
MaxCyte Inc | 393.6M | -10.6x | --- |
Envoy Medical Inc | 85.3M | -1.3x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $431.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-0.89 |
Book Value | $0.80 |
P/E Ratio | -8.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.